Sientra executives celebrate being listed on the Nasdaq after an IPO in October 2014. Sientra, the Goleta-based company that developed a breakthrough technology for breast implants, is in the fight of its short life as a public company. Mysterious particles that appeared in the sole factory it uses and the company’s failure to satisfy…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
